Live Analyst Rating Changes 3274 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Daniel Giraldo
BofA
Daniel Giraldo
Wall Street Analyst
Not yet ranked — too few measurable calls.
0%
Success Rate
-9.8%
Average Return
0 of 1 calls profitable · -8.8% vs benchmark
📈 Across the calls we could measure, roughly 0% of Daniel Giraldo's ratings turned a profit when each position was held for 1 year — averaging -9.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

12 Buy 0 Hold 0 Sell
Daniel's Stock Coverage 1 ratings · 2026-06-27
Company Date Position Consensus Price Target 1-Yr Return
FDMT
4D Molecular Therapeutics
May 08, 2026 BUY Strong Buy
+206.3% avg upside
15 analysts
$29.00
161.35% Upside
-9.8%
Daniel Giraldo — Frequently Asked Questions
How accurate are Daniel Giraldo's stock ratings?
Based on the calls 13Foresight could measure, about 0% of Daniel's ratings were profitable over a one-year hold, with an average return of -9.8% per rating, or -8.8% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Daniel ranked on 13Foresight?
Daniel Giraldo is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Daniel cover?
Daniel most recently has ratings on FDMT. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.